nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A prospective evaluation of transbronchial ultrasonography for assessment of depth of invasion in early bronchogenic squamous cell carcinoma
|
Takahashi, Hiroto |
|
2003 |
42 |
1 |
p. 43-49 7 p. |
artikel |
2 |
Bronchoscopic insertion of Gianturco stents for the palliation of malignant lung disease: 10 year experience
|
Stockton, P.A. |
|
2003 |
42 |
1 |
p. 113-117 5 p. |
artikel |
3 |
Calendar of Events
|
|
|
2003 |
42 |
1 |
p. vii- 1 p. |
artikel |
4 |
Contents
|
|
|
2003 |
42 |
1 |
p. v- 1 p. |
artikel |
5 |
Contents continued
|
|
|
2003 |
42 |
1 |
p. vi- 1 p. |
artikel |
6 |
Editorial Board
|
|
|
2003 |
42 |
1 |
p. IFC- 1 p. |
artikel |
7 |
Expression of cancer/testis (CT) antigens in lung cancer
|
Tajima, Kouhei |
|
2003 |
42 |
1 |
p. 23-33 11 p. |
artikel |
8 |
Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer
|
Wang, Li-E. |
|
2003 |
42 |
1 |
p. 1-8 8 p. |
artikel |
9 |
Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease
|
Gajra, Ajeet |
|
2003 |
42 |
1 |
p. 51-57 7 p. |
artikel |
10 |
Phase II clinical study of photodynamic therapy using mono-l-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung
|
Kato, Harubumi |
|
2003 |
42 |
1 |
p. 103-111 9 p. |
artikel |
11 |
Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer
|
Hoang, Tien |
|
2003 |
42 |
1 |
p. 97-102 6 p. |
artikel |
12 |
Preoperative carbon ion radiotherapy for non-small cell lung cancer with chest wall invasion—pathological findings concerning tumor response and radiation induced lung injury in the resected organs
|
Yamamoto, Naoyoshi |
|
2003 |
42 |
1 |
p. 87-95 9 p. |
artikel |
13 |
Pulmonary adenocarcinoma with massive lymphocyte infiltration: report of three cases
|
Minami, Yuko |
|
2003 |
42 |
1 |
p. 63-68 6 p. |
artikel |
14 |
Raising the public profile of lung cancer—report of a National Lung Cancer Awareness campaign in the UK
|
Baird, Jesme |
|
2003 |
42 |
1 |
p. 119-123 5 p. |
artikel |
15 |
Second primary tumors following adjuvant therapy of resected stages II and IIIa non-small cell lung cancer
|
Keller, Steven M. |
|
2003 |
42 |
1 |
p. 79-86 8 p. |
artikel |
16 |
Stimulation of the murine Uchl1 gene promoter by the B-Myb transcription factor
|
Long, Elizabeth M. |
|
2003 |
42 |
1 |
p. 9-21 13 p. |
artikel |
17 |
Substaging of stage I—a commentary
|
Watanabe, Yoh |
|
2003 |
42 |
1 |
p. 59-61 3 p. |
artikel |
18 |
The impact of residual multi-level N2 disease after induction therapy for non-small cell lung cancer
|
Sawabata, Noriyoshi |
|
2003 |
42 |
1 |
p. 69-77 9 p. |
artikel |
19 |
The sensitivity of lung cancer cell lines to the EGFR-selective tyrosine kinase inhibitor ZD1839 (‘Iressa’ 1 1 Iressa’ is a trademark of the AstraZeneca group of companies. ) is not related to the expression of EGFR or HER-2 or to K-ras gene status
|
Suzuki, Takeshi |
|
2003 |
42 |
1 |
p. 35-41 7 p. |
artikel |